Immunomedics CFO Pleads Guilty To Insider Trading About Breast Cancer Drug
NEWARK, N.J. — The former chief financial officer (CFO) of Immunomedics Inc. has pleaded guilty to one charge of insider trading, admitting that he gave insider information about a new drug...To view the full article, register now.
Already a subscriber? Click here to view full article